The mechanisms of action, efficacy, and side effects of ketogenic diet (KD) variations in epileptic patients.
Silence unveils more PhI data for siRNA drug in new cardiovascular race targeting Lp(a)
Silence Therapeutics’ siRNA asset showed hints of efficacy in cardiovascular disease patients enrolled in a Phase I trial amid recent readouts from pipeline rivals backed